Targeted therapies: the rare cancer paradigm.

Molecular Oncology
Marco A PierottiSilvana Pilotti

Abstract

This review analyzes the state of the art of targeted therapies for several tumors, starting from the paradigmatic example of Imatinib treatment in chronic myelogenous leukemia (CML). We discuss how rare tumors can be models for various mechanisms of receptor tyrosine kinase (RTK) activation, and provide the opportunity to develop new therapies also for more common cancer types. We discuss the activation of the downstream RTK effectors as further targets for therapies in colorectal cancer. Finally, we highlight how a novel multidimensional approach which adds an in silico dimension to the in vitro and in vivo approach, can predict clinical results.

References

Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·E BuchdungerN B Lydon
Apr 1, 1997·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·B A AlmanH J Wolfe
Feb 24, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J E Aubin, E Bonnelye
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·A GrecoM A Pierotti
Jul 27, 2001·Journal of Cancer Research and Clinical Oncology·W DempkeH J Schmoll
Feb 22, 2002·American Journal of Medical Genetics·J Aidan Carney, Constantine A Stratakis
Jul 3, 2002·Human Pathology·Christopher D M Fletcher
Aug 7, 2002·American Journal of Clinical Pathology·Christopher D M Fletcher, Jonathan A Fletcher
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Robert G MakiCristina R Antonescu
Sep 1, 1960·Experimental Cell Research·P S MOORHEADD A HUNGERFORD
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzRobert J Mayer
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher L CorlessMichael C Heinrich
Sep 17, 2004·Cancer·Paolo G CasaliSilvana Pilotti
Oct 2, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S RaoP A Palmer
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John RinehartMark B Meyer
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grant A McArthurJonathan A Fletcher
Mar 30, 2005·Ear, Nose, & Throat Journal·Enrique Palacios
Apr 2, 2005·American Journal of Clinical Oncology·William M MendenhallMark T Scarborough
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederick P LiGeorge D Demetri
Aug 17, 2005·Archives of Otolaryngology--head & Neck Surgery·Paul M WeinbergerClarence T Sasaki
Nov 19, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Wim G GoettschPancras C W Hogendoorn
Nov 29, 2005·The Orthopedic Clinics of North America·Onder Ofluoglu
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Robert B WestMatt van de Rijn
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
May 26, 2006·Nature·Reuben J Shaw, Lewis C Cantley
Oct 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heinz-Josef LenzEric K Rowinsky
Oct 25, 2006·Molecular and Cellular Biology·Jung-Sik KimTodd Waldman
Nov 2, 2006·Journal of the National Cancer Institute·Elena TamboriniSilvana Pilotti
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elena TamboriniSilvana Pilotti

❮ Previous
Next ❯

Citations

Jun 1, 2012·Expert Opinion on Drug Discovery·Matthew JessulatAshkan Golshani
Aug 13, 2010·Expert Opinion on Drug Metabolism & Toxicology·Shu-Ming HeShu-Feng Zhou
Aug 10, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Federica PerroneSilvana Pilotti
Apr 10, 2013·Molecular Oncology·Elena ConcaElena Tamborini
Oct 27, 2010·Molecular Oncology·Claudius MuellerVirginia Espina
Sep 11, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Fabio BozziSilvana Pilotti
Dec 8, 2017·Journal of Biomaterials Science. Polymer Edition·Samad Hosseini SadrAli Ramazani
Nov 11, 2017·Molecular Oncology·Sara SigismundLetizia Lanzetti
Mar 3, 2011·Nature Reviews. Clinical Oncology·Marco A PierottiSilvana Pilotti
Jan 17, 2015·Oncotarget·Abbes Belkhiri, Wael El-Rifai
Dec 24, 2010·Molecular Cancer Therapeutics·Graham C FletcherMark R Bray
Dec 21, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A F LearyUNKNOWN participants of the Fifth Ovarian Cancer Consensus Conference

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

© 2022 Meta ULC. All rights reserved